Logo Image
Opinion|Videos|September 24, 2025

Future Treatment of Patients With Alopecia Areata

Key Takeaways

  • Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles.
  • Breakdown of immune privilege in hair follicles leads to infiltration by cytotoxic T cells, particularly CD8+ T cells.
SHOW MORE

Panelists discuss how the introduction of Janus kinase (JAK) inhibitor therapies will likely change treatment algorithms for alopecia areata (AA), with insights on how payers should plan for coverage in the coming years and explore the biggest unmet needs for patients with AA and potential improvements in care.

Episodes in this series

Video content above is prompted by the following:

  1. McMichael: How do you see treatment algorithms changing with the introduction of JAK inhibitor therapies?
    1. How do you think payers should anticipate covering AA in the next few years?
  2. Friedland: What do you see as the biggest unmet needs for patients with AA and how can these be improved in the future?

Related Content